The autonomic nervous system and cardiovascular disease: Role of n-3 PUFAs

Vascular Pharmacology

Volumn 71, Issue , 2015, Pages 1-10

  La Rovere, Maria Teresa ^a   Christensen, Jeppe Hagstrup ^b  

^a IRCCS   (Italy)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autonomic nervous system; Baroreflex sensitivity; Cardiovascular disease; Heart rate variability; N 3 PUFA

Indexed keywords

OMEGA 3 FATTY ACID;

ATHEROSCLEROTIC PLAQUE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CEREBROVASCULAR ACCIDENT; DIETARY INTAKE; DOSE RESPONSE; DRUG MEGADOSE; DRUG STRUCTURE; DYSLIPIDEMIA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOW DRUG DOSE; MUSCLE SYMPATHETIC NERVE ACTIVITY; NEUROMODULATION; NONHUMAN; OBESITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; RR INTERVAL; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DRUG EFFECTS; HEART RATE; METABOLISM; NERVE TRACT; PHYSIOLOGY; VAGUS NERVE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; HEART RATE; HUMANS; NEURAL PATHWAYS; VAGUS NERVE;

EID: 84937966278     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.02.005     Document Type: Review

References (87)

1. Shen M.J., Zipes D.P. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res 2014, 114:1004-1021.
2. Eckberg D.L., Sleight P. Human baroreflexes in heart and disease 1992, Clarendon Press, Oxford.
3. Pickering T.G., Davies J. Estimation of the conduction time of the baroreceptor cardiac reflex in man. Cardiovasc Res 1973, 7:213-219.
4. Schwartz P.J., Vanoli E., Stramba-Badiale M., De Ferrari G.M., Billman G.E., Foreman R.D. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988, 78:969-979.
5. Wang W., Chen J.S., Zucker I.H. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 1990, 81:1959-1966.
6. Eckberg D.L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic in patients with heart disease. N Engl J Med 1971, 285:877-883.
7. La Rovere M.T., Bigger J.T., Marcus F.I., Mortara A., Schwartz P.J. For the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998, 351:478-484.
8. La Rovere M.T., Pinna G.D., Hohnloser S.H., Marcus F.I., Mortara A., Nohara R., et al. For the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Implications for clinical trials. Circulation 2001, 103:2072-2077.
9. La Rovere M.T., Pinna G.D., Maestri R., Robbi E., Caporotondi A., Guazzotti G., Sleight P. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 2009, 53:193-199.
10. De Meersman R.E., Stein P.K. Vagal modulation and aging. Biol Psychol 2007, 74:165-173.
11. Laitinen T., Hartikainen J., Vanninen E., Niskanen L., Geelen G., Länsimies E. Age and gender dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol 1998, 84:535-540.
12. Monahan K.D., Tanaka H., Dinenno F.A., Seals D.R. Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensitivity. Circulation 2001, 104:1627-1632.
13. Huikuri H.V., Mäkikallio T.H., Airaksinen K.E., Seppänen T., Puukka P., Räihä I.J., et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 1998, 97:2031-2036.
14. Huikuri H.V., Pikkujämsä S.M., Airaksinen K.E., Ikäheimo M.J., Rantala A.O., Kauma H., et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996, 94:122-125.
15. Esler M. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol 2011, 96:611-622.
16. Weimer L.H. Autonomic testing: common techniques and clinical applications. Neurologist 2010, 16:215-222.
17. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996, 17:354-381.
18. Tsuji H., Larson M.G., Venditti F.J., Manders E.S., Evans J.C., Feldman C.L., et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham heart study. Circulation 1996, 94:2850-2855.
19. Kleiger R.E., Miller J.P., Bigger J.T., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987, 59:256-262.
20. La Rovere M.T., Pinna G.D., Maestri R., Mortara A., Capomolla S., Febo O., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003, 107:565-570.
21. Dekker J.M., Schouten E.G., Klootwijk P., Pool J., Swenne C.A., Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen study. Am J Epidemiol 1997, 145:899-908.
22. Christensen J.H. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan Med Bull 2003, 50:347-367.
23. Smyth H.S., Sleight P., Pickering G.W. Reflex regulation of arterial pressure during sleep in man. A quantitative method for assessing baroreflex sensitivity. Circ Res 1969, 24:109-121.
24. Bang H.O., Dyerberg J., Nielsen A.B. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Lancet 1971, 1(7710):1143-1145.
25. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009, 77:937-946.
26. Wassall S.R., Stillwell W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. Biochim Biophys Acta 1788, 2009:24-32.
27. Li Q., Wang M., Tan L., Wang C., Ma J., Li N., et al. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res 2005, 46:1904-1913.
28. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 Suppl.):1505S-1519S.
29. Sun C., Wei Z.W., Li Y. DHA regulates lipogenesis and lipolysis genes in mice adipose and liver. Mol Biol Rep 2011, 38:731-737.
30. Innis S.M. Dietary (n-3) fatty acids and brain development. J Nutr 2007, 137:855-859.
31. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58:2047-2067.
32. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med 2011, 364:2439-2450.
33. Zheng J., Huang T., Yu Y., Hu X., Yang B., Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr 2012, 15:725-737.
34. Sekikawa A., Curb J.D., Ueshima H., El-Saed A., Kadowaki T., Abbott R.D., et al. ERA JUMP (Electron-Beam Tomography, risk factor assessment among Japanese and U.S. men in the post-World War II birth cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008, 52:417-424.
35. Xun P., Qin B., Song Y., Nakamura Y., Kurth T., Yaemsiri S., et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies. Eur J Clin Nutr 2012, 66:1199-1207.
36. Albert C.M., Hennekens C.H., O'Donnell C.J., Ajani U.A., Carey V.J., Willett W.C., et al. Fish consumption and risk of sudden cardiac death. JAMA 1998, 279:23-28.
37. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
38. Streppel M.T., Ocké M.C., Boshuizen H.C., Kok F.J., Kromhout D. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J 2008, 29:2024-2030.
39. Kimmig L.M., Karalis D.G. Do omega-3 polyunsaturated fatty acids prevent cardiovascular disease? A review of the randomized clinical trials. Lipid Insights 2013, 6:13-20.
40. Rizos E.C., Ntzani E.E., Bika E., Kostapanos M.S., Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012, 308:1024-1033.
41. Lewis E.J.H. Omega-3 fatty acid supplementation and cardiovascular disease events. Letter JAMA 2013, 309:27.
42. Vlachopoulos C., Richter D., Stefanadis C. Omega n-3 fatty acid supplementation and cardiovascular disease events. Letter JAMA 2013, 309:27.
43. Delgado-Lista J., Perez-Martinez P., Lopez-Miranda J., Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 2012, 107(Suppl. 2):S201-S213.
44. Kwak S.M., Myung S.K., Lee Y.J., Seo H.G. Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 2012, 172:686-694.
45. DiNicolantonio J.J., O'Keefe J.H., Lavie C.J. The big ones that got away: omega-3 meta-analysis flawed by excluding the biggest fish oil trials. Arch Intern Med 2012, 172:1427.
46. DiNicolantonio J.J., Niazi A.K., McCarty M.F., O'Keefe J.H., Meier P., Lavie C.J. Omega-3 s and cardiovascular health. Ochsner J 2014, 14:399-412.
47. Losurdo P., Grillo A., Panizon E., Zanetti M., Bardelli M., Biolo G., et al. Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause. Vascul Pharmacol 2015, 71:65-69.
48. Mozaffarian D., Stein P.K., Prineas R.J., Siscovick D.S. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 2008, 117(9):1130-1137.
49. Christensen J.H., Christensen M.S., Dyerberg J., Schmidt E.B. Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr 1999, 70:331-337.
50. Brouwer I.A., Zock P.L., van Amelsvoort L.G., Katan M.B., Schouten E.G. Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. Am J Cardiol 2002, 89:629-631.
51. Valera B., Dewailly E., Anassour-Laouan-Sidi E., Poirier P. Influence of n-3 fatty acids on cardiac autonomic activity among Nunavik Inuit adults. Int J Circumpolar Health 2011, 70:6-18.
52. Harbaugh M.P., Manuck S.B., Jennings J.R., Conklin S.M., Yao J.K., Muldoon M.F. Long-chain, n-3 fatty acids and physical activity - independent and interactive associations with cardiac autonomic control. Int J Cardiol 2013, 167:2102-2107.
53. Christensen J.H., Gustenhoff P., Korup E., Aarøe J., Toft E., Møller J., et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 1996, 312(7032):677-678.
54. Christensen J.H., Korup E., Aarøe J., Toft E., Møller J., Rasmussen K., et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997, 79:1670-1673.
55. Christensen J.H., Skou H.A., Fog L., Hansen V., Vesterlund T., Dyerberg J., et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 2001, 103:651-657.
56. Villa B., Calabresi L., Chiesa G., Risè P., Galli C., Sirtori C.R. Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res 2002, 45:475.
57. Christensen J.H., Aarøe J., Knudsen N., Dideriksen K., Kornerup H.J., Dyerberg J., et al. Heart rate variability and n-3 fatty acids in patients with chronic renal failure-a pilot study. Clin Nephrol 1998, 49:102-106.
58. Fiedler R., Mall M., Wand C., Osten B. Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr 2005, 15:253-256.
59. Svensson M., Schmidt E.B., Jørgensen K.A., Christensen J.H. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis. J Ren Nutr 2007, 17:243-249.
60. Ninio D.M., Hill A.M., Howe P.R., Buckley J.D., Saint D.A. Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults. Br J Nutr 2008, 100:1097-1103.
61. Kim S.H., Kim M.K., Lee H.Y., Kang H.J., Kim Y.J., Kim H.S. Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability. Eur J Clin Nutr 2011, 65:110-116.
62. Christensen J.H., Skou H.A., Madsen T., Tørring I., Schmidt E.B. Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med 2001, 249:545-552.
63. Santini V., Ciampittiello G., Gigli F., Bracaglia D., Baroni A., Cicconetti E., et al. QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA. Nutr Metab Cardiovasc Dis 2007, 17:712-718.
64. Sjoberg N.J., Milte C.M., Buckley J.D., Howe P.R., Coates A.M., Saint D.A. Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation. Br J Nutr 2010, 103:243-248.
65. Sauder K.A., Skulas-Ray A.C., Campbell T.S., Johnson J.A., Kris-Etherton P.M., West S.G. Effects of omega-3 fatty acid supplementation on heart rate variability at rest and during acute stress in adults with moderate hypertriglyceridemia. Psychosom Med 2013, 75:382-389.
66. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
67. Grimsgaard S., Bønaa K.H., Hansen J.B., Myhre E.S. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 1998, 68:52-59.
68. Mozaffarian D., Geelen A., Brouwer I.A., Geleijnse J.M., Zock P.L., Katan M.B. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112:1945-1952.
69. Palatini P., Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004, 26:637-644.
70. Geelen A., Zock P.L., Swenne C.A., Brouwer I.A., Schouten E.G., Katan M.B. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am Heart J 2003, 146(2):E4.
71. Dyerberg J., Eskesen D.C., Andersen P.W., Astrup A., Buemann B., Christensen J.H., et al. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8weeks dietary intervention study. Eur J Clin Nutr 2004, 58:1062-1070.
72. La Rovere M.T., Staszewsky L., Barlera S., Maestri R., Mezzani A., Midi P., et al. GISSI-HF investigators. n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy. Heart Rhythm 2013, 10:226-232.
73. Nodari S., Metra M., Milesi G., Manerba A., Cesana B.M., Gheorghiade M., et al. The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther 2009, 23:5-15.
74. O'Keefe J.H., Abuissa H., Sastre A., Steinhaus D.M., Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006, 97(8):1127-1130.
75. Radaelli A., Cazzaniga M., Viola A., Balestri G., Janetti M.B., Signorini M.G., et al. Enhanced baroreceptor control of the cardiovascular system by polyunsaturated fatty acids in heart failure patients. J Am Coll Cardiol 2006, 48:1600-1606.
76. Hamaad A., Kaeng Lee W., Lip G.Y., MacFadyen R.J. Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovasc Drugs Ther 2006, 20:359-364.
77. Carney R.M., Freedland K.E., Stein P.K., Steinmeyer B.C., Harris W.S., Rubin E.H., et al. Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease. Psychosom Med 2010, 72:748-754.
78. Holguin F., Téllez-Rojo M.M., Lazo M., Mannino D., Schwartz J., Hernández M., et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 2005, 127:1102-1107.
79. DeGiorgio C.M., Miller P., Meymandi S., Gornbein J.A. n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy Behav 2008, 13:681-684.
80. Weisser B., Struck A., Göbel B.O., Vetter H., Düsing R. Fish oil and baroreceptor function in man. Klin Wochenschr 1990, 68(Suppl. 20):49-52.
81. Mills D.E., Mah M., Ward R.P., Morris B.L., Floras J.S. Alteration of baroreflex control of forearm vascular resistance by dietary fatty acids. Am J Physiol 1990, 259(6 Pt 2):R1164-R1171.
82. Matsumura K., Yamakoshi T., Noguchi H., Rolfe P., Matsuoka Y. Fish consumption and cardiovascular response during mental stress. BMC Res Notes 2012, 5:288.
83. Carter J.R., Schwartz C.E., Yang H., Joyner M.J. Fish oil and neurovascular reactivity to mental stress in humans. Am J Physiol Regul Integr Comp Physiol 2013, 304:R523-R530.
84. Hamazaki K., Itomura M., Huan M., Nishizawa H., Sawazaki S., Tanouchi M., et al. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial. Nutrition 2005, 21:705-710.
85. Billman G.E. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment. Pharmacol Ther 2013, 140:53-80.
86. Verkerk A.O., den Ruijter H.M., Bourier J., Boukens B.J., Brouwer I.A., Wilders R., et al. Dietary fish oil reduces pacemaker current and heart rate in rabbit. Heart Rhythm 2009, 6:1485-1492.
87. Harris W.S., Gonzales M., Laney N., Sastre A., Borkon A.M. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol 2006, 98:1393-1395.